Romatolojik Hastalıkların Nörolojik Manifestasyonları: Vaskülitlerin nörolojik manifestasyonları

Cabral DA, Ozen S, Morishita KA. Vasculitis and its classification. In: Textbook of Pediatric Rheumatology, 8th ed, Petty RE, Laxer RM, Lindsley CB, et al (Eds), Elsevier, 2021. p.448-451.

Schnabel A, Hedrich CM. Childhood Vasculitis. Front Pediatr. 2019;6:421. Published 2019 Jan 10. doi:10.3389/fped.2018.00421

Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. doi:10.1002/art.37715

Fries JF, Hunder GG, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33(8):1135-1136. doi:10.1002/art.1780330812

Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936-941. doi:10.1136/ard.2005.046300

Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69(5):798-806. doi:10.1136/ard.2009.116657

Bowyer S, Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J Rheumatol. 1996;23(11):1968-1974.

Ozen S. Problems in classifying vasculitis in children. Pediatr Nephrol. 2005;20(9):1214-1218. doi:10.1007/s00467-005-1911-z

Baldursson O, Steinsson K, Björnsson J, Lie JT. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum. 1994;37(7):1007-1012. doi:10.1002/art.1780370705

Trnka P. Henoch-Schönlein purpura in children. J Paediatr Child Health. 2013;49(12):995-1003. doi:10.1111/jpc.12403

Ozen S, Bakkaloglu A, Dusunsel R, et al. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol. 2007;26(2):196-200. doi:10.1007/s10067-006-0266-6

Brogan PA, Eleftheriou D. Paediatric vasculitis. In:Watts RA, Conaghan PG, Denton C, Foster H, Isaacs j, Müller-Ladner u eds. oxford Textbook of Rheumotology. 4th ed. New York: oxford university. 2013. p.1141-52.

Brogan P, Bagga A. Leukocytoclastic Vasculitis: Henoch–Schönlein Purpura and Hypersensitivity Vasculitis. In: Textbook of Pediatric Rheumatology, 8th ed, Petty RE, Laxer RM, Lindsley CB, et al (Eds), Elsevier, 2021. p.452-461.

Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360(9341):1197-1202. doi:10.1016/S0140-6736(02)11279-7

González-Gay MA, García-Porrúa C. Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001;27(4):729-749. doi:10.1016/s0889-857x(05)70232-5

López-Mejías R, Castañeda S, Genre F, et al. Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review. Autoimmun Rev. 2018;17(3):301-315. doi:10.1016/j.autrev.2017.11.024

Levinsky RJ, Barratt TM. IgA immune complexes in Henoch-Schönlein purpura. Lancet. 1979;2(8152):1100-1103. doi:10.1016/s0140-6736(79)92505-4

Yıldırım S, Ergüven M. Primer küçük damar vaskülitleri: İmmün kompleks ilişkili küçük damar vaskülitleri: IgA vasküliti (Henoch- Schönlein purpurası). Ergüven M, editör. Çocukluk Çağı Vaskülitleri. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.44-51.

Paolini S, Ciappetta P, Piattella MC, Domenicucci M. Henoch-Schönlein syndrome and cerebellar hemorrhage: report of an adolescent case and literature review. Surg Neurol. 2003;60(4):339-342. doi:10.1016/s0090-3019(03)00166-6

Goraya JS, Jayashree M, Ghosh D, Singh S, Singhi SC, Kumar L. Guillain-Barré syndrome in a child with Henoch-Schönlein Purpura. Scand J Rheumatol. 1998;27(4):310-312. doi:10.1080/030097498442451

A. Bulun, R. Topaloglu, A. Duzova, et al., Ataxia and peripheral neuropathy: rare manifestations in Henoch-Schönlein purpura, Pediatr. Nephrol. 16 (2001) 1139–1141.

Garzoni L, Vanoni F, Rizzi M, et al. Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Rheumatology (Oxford). 2009;48(12):1524-1529. doi:10.1093/rheumatology/kep282

Liu A, Zhang H. Detection of antiphospholipid antibody in children with Henoch-Schönlein purpura and central nervous system involvement. Pediatr Neurol. 2012;47(3):167-170. doi:10.1016/j.pediatrneurol.2012.05.024

Hamano H, Matsushige T, Inoue H, et al. A case of acute encephalophathy with residual neurological sequelae induced by immunoglobulin A vasculitis. J Clin Neurosci. 2019;67:270-271. doi:10.1016/j.jocn.2019.05.061

Chen TH. Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome. Front Pediatr. 2020;8:585. Published 2020 Sep 11. doi:10.3389/fped.2020.00585

Pacheva IH, Ivanov IS, Stefanova K, et al. Central Nervous System Involvement in Henoch-Schonlein Purpura in Children and Adolescents. Case Rep Pediatr. 2017;2017:5483543. doi:10.1155/2017/5483543

Lava SA, Peeters GG, Bianchetti MG, Goeggel Simonetti B, Simonetti GD, Milani GP. Posterior reversible encephalopathy syndrome in Henoch-Schönlein purpura. Rheumatol Int. 2017;37(3):461-463. doi:10.1007/s00296-016-3577-1

Tabel Y. Henoch Schönlein Purpurası (IgA Vasküliti) ve Diğer Lökositoklastik Vaskülitler. In: Poyrazoğlu M.H, Sözeri B. Çocuk Romatoloji. Ankara, Güneş Medical Book store, 2018.p.195-201

Son M.B, Sundel R.P. Kawasaki Disease. In: Textbook of Pediatric Rheumatology, 8th ed, Petty RE, Laxer RM, Lindsley CB, et al (Eds), Elsevier, 2021. p.467-483.

Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol. 2020;16(7):391-405. doi:10.1038/s41584-020-0426-0

Wittkowski H, Hirono K, Ichida F, et al. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12. Arthritis Rheum. 2007;56(12):4174-4181. doi:10.1002/art.23042

Liu X, Zhou K, Hua Y, et al. Neurological involvement in Kawasaki disease: a retrospective study. Pediatr Rheumatol Online J. 2020;18(1):61. Published 2020 Jul 14. doi:10.1186/s12969-020-00452-7

Tabarki B, Mahdhaoui A, Selmi H, Yacoub M, Essoussi AS. Kawasaki disease with predominant central nervous system involvement. Pediatr Neurol. 2001;25(3):239-241. doi:10.1016/s0887-8994(01)00290-9

Sabatier I, Chabrier S, Brun A, et al. Stroke by carotid artery complete occlusion in Kawasaki disease: case report and review of literature. Pediatr Neurol. 2013;49(6):469-473. doi:10.1016/j.pediatrneurol.2013.08.011

Yeom JS, Cho JY, Woo HO. Understanding the importance of cerebrovascular involvement in Kawasaki disease. Korean J Pediatr. 2019;62(9):334-339. doi:10.3345/kjp.2019.00143

Yüksel S, Evrengül H. Poliarteritis Nodoza ve Kütanöz Poliarteritis Nodoza.In: Poyrazoğlu M.H, Sözeri B. Çocuk Romatoloji. Ankara, Güneş Medical Book store, 2018.p.203-213

Ozen S, Anton J, Arisoy N, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr. 2004;145(4):517-522. doi:10.1016/j.jpeds.2004.06.046

Watts R.A., Scott D.G.I. Epidemiology of vasculitis, in: Ball G.V., Bridges S.L. (Eds.), Vasculitis, second ed., Oxford University Press, Oxford, 2008, pp. 7–21.

Eleftheriou D, Ozen S. Polyarteritis Nodosa. In: Textbook of Pediatric Rheumatology, 8th ed, Petty RE, Laxer RM, Lindsley CB, et al (Eds), Elsevier, 2021. p.462-466.

Shimojima Y, Ishii W, Kishida D, Fukushima K, Ikeda SI. Imbalanced expression of dysfunctional regulatory T cells and T-helper cells relates to immunopathogenesis in polyarteritis nodosa. Mod Rheumatol. 2017;27(1):102-109. doi:10.3109/14397595.2016.1172999

Guillevin L, Lhote F, Amouroux J, Gherardi R, Callard P, Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol. 1996;35(10):958-964. doi:10.1093/rheumatology/35.10.958

Fink CW. The role of the streptococcus in poststreptococcal reactive arthritis and childhood polyarteritis nodosa. J Rheumatol Suppl. 1991;29:14-20.

Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, et al. Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology (Oxford). 2020;59(6):1372-1380. doi:10.1093/rheumatology/kez410

Dillon MJ, Eleftheriou D, Brogan PA. Medium-size-vessel vasculitis. Pediatr Nephrol. 2010;25(9):1641-1652. doi:10.1007/s00467-009-1336-1

Eleftheriou D, Dillon MJ, Tullus K, et al. Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum. 2013;65(9):2476-2485. doi:10.1002/art.38024

Kasap Cuceoglu M, Sener S, Batu ED, et al. Systematic review of childhood-onset polyarteritis nodosa and DADA2. Semin Arthritis Rheum. 2021;51(3):559-564. doi:10.1016/j.semarthrit.2021.04.009

Sönmez HE, Armağan B, Ayan G, et al. Polyarteritis nodosa: lessons from 25 years of experience. Clin Exp Rheumatol. 2019;37 Suppl 117(2):52-56.

Erden A, Batu ED, Sönmez HE, et al. Comparing polyarteritis nodosa in children and adults: a single center study. Int J Rheum Dis. 2017;20(8):1016-1022. doi:10.1111/1756-185X.13120

Iudici M, Quartier P, Pagnoux C, et al. Childhood- versus Adult-Onset Polyarteritis Nodosa Results from the French Vasculitis Study Group Registry. Autoimmun Rev. 2018;17(10):984-989. doi:10.1016/j.autrev.2018.08.001

Guirola R, Hunter JV, Perez M, Muscal E. Childhood polyarteritis nodosa presenting with central nervous system manifestations and the posterior reversible encephalopathy syndrome. J Child Neurol. 2014;29(1):103-107. doi:10.1177/0883073812465339

Falcini F, La Torre F, Vittadello F, et al. Clinical overview and outcome in a cohort of children with polyarteritis nodosa. Clin Exp Rheumatol. 2014;32(3 Suppl 82):S134-S137.

de Boysson H, Guillevin L. Polyarteritis Nodosa Neurologic Manifestations. Neurol Clin. 2019;37(2):345-357. doi:10.1016/j.ncl.2019.01.007

Demir S, Bilginer Y. Primer-orta damar vaskülitleri: Poliarteritis nodoza ve adenozin deaminaz- 2 eksikliği. Ergüven M, editör. Çocukluk Çağı Vaskülitleri. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.21-6.

Meyts I, Aksentijevich I. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment. J Clin Immunol. 2018;38(5):569-578. doi:10.1007/s10875-018-0525-8

Navon Elkan P, Pierce SB, Segel R, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10):921-931. doi:10.1056/NEJMoa1307362

Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911-920. doi:10.1056/NEJMoa1307361

Van Montfrans JM, Hartman EA, Braun KP, et al. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatology (Oxford). 2016;55(5):902-910. doi:10.1093/rheumatology/kev439

Belot A, Wassmer E, Twilt M, et al. Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J. 2014;12:44. Published 2014 Sep 24. doi:10.1186/1546-0096-12-44

Batu ED, Karadag O, Taskiran EZ, et al. A Case Series of Adenosine Deaminase 2-deficient Patients Emphasizing Treatment and Genotype-phenotype Correlations. J Rheumatol. 2015;42(8):1532-1534. doi:10.3899/jrheum.150024

Uettwiller F, Sarrabay G, Rodero MP, et al. ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters. RMD Open. 2016;2(1):e000236. Published 2016 May 16. doi:10.1136/rmdopen-2015-000236

de Graeff N, Groot N, Brogan P, et al. European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative [published correction appears in Rheumatology (Oxford). 2020 Apr 1;59(4):919. doi: 10.1093/rheumatology/keaa057]. Rheumatology (Oxford). 2019;58(4):656-671. doi:10.1093/rheumatology/key322

Conticini E, Sota J, Falsetti P, et al. Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: A narrative review. Autoimmun Rev. 2021;20(4):102784. doi:10.1016/j.autrev.2021.102784

Mathew AJ, Goel R, Kumar S, Danda D. Childhood-onset Takayasu arteritis: an update. Int J Rheum Dis. 2016;19(2):116-126. doi:10.1111/1756-185X.12718

Aeschlimann FA, Barra L, Alsolaimani R, et al. Presentation and Disease Course of Childhood-Onset Versus Adult-Onset Takayasu Arteritis [published correction appears in Arthritis Rheumatol. 2020 Jun;72(6):1035. doi: 10.1002/art.41292]. Arthritis Rheumatol. 2019;71(2):315-323. doi:10.1002/art.40690

Goel R, Sathish Kumar T, Danda D. Childhood-Onset Takayasu Arteritis (c-TA): Current and Future Drug Therapy. Paediatr Drugs. 2019;21(2):81-93. doi:10.1007/s40272-019-00327-9

Sahin S, Hopurcuoglu D, Bektas S, et al. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center. Int J Rheum Dis. 2019;22(1):132-139. doi:10.1111/1756-185X.13425

Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919-929. doi:10.7326/0003-4819-120-11-199406010-00004

Di Santo M, Stelmaszewski EV, Villa A. Takayasu arteritis in paediatrics. Cardiol Young. 2018;28(3):354-361. doi:10.1017/S1047951117001998

Numano F. Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol. 2000;75 Suppl 1:S1-S19. doi:10.1016/s0167-5273(00)00196-0

Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev. 2011;11(1):61-67. doi:10.1016/j.autrev.2011.08.001

Park MC, Lee SW, Park YB, Lee SK. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology (Oxford). 2006;45(5):545-548. doi:10.1093/rheumatology/kei266

Brunner J, Feldman BM, Tyrrell PN, et al. Takayasu arteritis in children and adolescents. Rheumatology (Oxford). 2010;49(10):1806-1814. doi:10.1093/rheumatology/keq167

Clemente G, Hilário MO, Len C, et al. Brazilian multicenter study of 71 patients with juvenile-onset Takayasu's arteritis: clinical and angiographic features. Rev Bras Reumatol Engl Ed. 2016;56(2):145-151. doi:10.1016/j.rbre.2016.01.004

Goel R, Kumar TS, Danda D, et al. Childhood-onset Takayasu arteritis -- experience from a tertiary care center in South India. J Rheumatol. 2014;41(6):1183-1189. doi:10.3899/jrheum.131117

Szugye HS, Zeft AS, Spalding SJ. Takayasu Arteritis in the pediatric population: a contemporary United States-based single center cohort. Pediatr Rheumatol Online J. 2014;12:21. Published 2014 Jun 4. doi:10.1186/1546-0096-12-21

Eleftheriou D, Varnier G, Dolezalova P, McMahon AM, Al-Obaidi M, Brogan PA. Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. Arthritis Res Ther. 2015;17(1):36. Published 2015 Feb 25. doi:10.1186/s13075-015-0545-1

Misra DP, Aggarwal A, Lawrence A, Agarwal V, Misra R. Pediatric-onset Takayasu's arteritis: clinical features and short-term outcome. Rheumatol Int. 2015;35(10):1701-1706. doi:10.1007/s00296-015-3272-7

Fan L, Zhang H, Cai J, et al. Clinical course and prognostic factors of childhood Takayasu's arteritis: over 15-year comprehensive analysis of 101 patients [published correction appears in Arthritis Res Ther. 2019 Feb 14;21(1):55. doi: 10.1186/s13075-019-1844-8]. Arthritis Res Ther. 2019;21(1):31. Published 2019 Jan 22. doi:10.1186/s13075-018-1790-x

Aeschlimann FA, Eng SWM, Sheikh S, et al. Childhood Takayasu arteritis: disease course and response to therapy. Arthritis Res Ther. 2017;19(1):255. Published 2017 Nov 22. doi:10.1186/s13075-017-1452-4

Porter A, Youngstein T, Tombetti E, Mason JC. Biologic therapy in supra-aortic Takayasu arteritis can improve symptoms of cerebral ischaemia without surgical intervention. Rheumatology (Oxford). 2020;59(Suppl 3):iii28-iii32. doi:10.1093/rheumatology/kez616

Bolek EC, Kaya Akca U, Sari A, et al. Is Takayasu's arteritis more severe in children?. Clin Exp Rheumatol. 2021;39 Suppl 129(2):32-38. doi:10.55563/clinexprheumatol/kr357t

Dai Y, Zhong Y, Jian B, et al. Bridging Therapy for Acute Stroke as the Initial Manifestation of Takayasu Arteritis: A Case Report and Review of Literature. Front Immunol. 2021;12:630619. Published 2021 Apr 30. doi:10.3389/fimmu.2021.630619

Sönmez HE, Demir F, Özdel S, et al. Neuroimaging of Children With Takayasu Arteritis. J Child Neurol. 2021;36(8):642-647. doi:10.1177/0883073821991287

Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J. 1977;93(1):94-103. doi:10.1016/s0002-8703(77)80178-6

Mavrogeni S, Dimitroulas T, Chatziioannou SN, Kitas G. The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum. 2013;42(4):401-412. doi:10.1016/j.semarthrit.2012.07.005

Sacri AS, Chambaraud T, Ranchin B, et al. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study. Nephrol Dial Transplant. 2015;30 Suppl 1:i104-i112. doi:10.1093/ndt/gfv011

Cabral DA, Canter DL, Muscal E, et al. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. Arthritis Rheumatol. 2016;68(10):2514-2526. doi:10.1002/art.39729

Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol. 2014;10(8):463-473. doi:10.1038/nrrheum.2014.103

Kiene M, Csernok E, Müller A, Metzler C, Trabandt A, Gross WL. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum. 2001;44(2):469-473. doi:10.1002/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0

Morishita KA, Moorthy LN, Lubieniecka JM, et al. Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2017;69(7):1470-1479. doi:10.1002/art.40112

Hirano D, Ishikawa T, Inaba A, et al. Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis. Pediatr Nephrol. 2019;34(8):1425-1433. doi:10.1007/s00467-019-04228-4

Özçelik G, Sönmez HE, Şahin S, et al. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis. Pediatr Nephrol. 2019;34(5):847-854. doi:10.1007/s00467-018-4162-5

Wang JC, Leader BA, Crane RA, Koch BL, Smith MM, Ishman SL. Granulomatosis with polyangiitis presenting as facial nerve palsy in a teenager. Int J Pediatr Otorhinolaryngol. 2018;107:160-163. doi:10.1016/j.ijporl.2018.02.009

Higuera-Ortiz V, Reynoso A, Ruiz N, Delgado-Hernández RD, Gómez-Garza G, Flores-Suárez LF. Pachymeningitis in granulomatosis with polyangiitis: case series with earlier onset in younger patients and literature review. Clin Rheumatol. 2017;36(4):919-924. doi:10.1007/s10067-016-3520-6

Kara O, Demirel F, Acar BC, Cakar N. Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood. J Pediatr Endocrinol Metab. 2013;26(9-10):959-962. doi:10.1515/jpem-2013-0033

Gendelman S, Zeft A, Spalding SJ. Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort. J Rheumatol. 2013;40(6):929-935. doi:10.3899/jrheum.120808

Eleftheriou D, Gale H, Pilkington C, Fenton M, Sebire NJ, Brogan PA. Eosinophilic granulomatosis with polyangiitis in childhood: retrospective experience from a tertiary referral centre in the UK. Rheumatology (Oxford). 2016;55(7):1263-1272. doi:10.1093/rheumatology/kew029

Fina A, Dubus JC, Tran A, et al. Eosinophilic granulomatosis with polyangiitis in children: Data from the French RespiRare® cohort. Pediatr Pulmonol. 2018;53(12):1640-1650. doi:10.1002/ppul.24089

De Luna G, Terrier B, Kaminsky P, et al. Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes. Rheumatology (Oxford). 2015;54(3):424-432. doi:10.1093/rheumatology/keu336

Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol. 1998;25(12):2445-2449.

Sarica R, Azizlerli G, Köse A, Dişçi R, Ovül C, Kural Z. Juvenile Behçet's disease among 1784 Turkish Behçet's patients. Int J Dermatol. 1996;35(2):109-111. doi:10.1111/j.1365-4362.1996.tb03272.x

Koné-Paut I, Shahram F, Darce-Bello M, et al. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75(6):958-964. doi:10.1136/annrheumdis-2015-208491

Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol. 2003;87(9):1175-1183. doi:10.1136/bjo.87.9.1175

DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 2009;60(9):2633-2643. doi:10.1002/art.24763

Gul A, Ohno S. HLA-B*51 and Behçet Disease. Ocul Immunol Inflamm. 2012;20(1):37-43. doi:10.3109/09273948.2011.634978

Gallizzi R, Pidone C, Cantarini L, et al. A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry [published correction appears in Pediatr Rheumatol Online J. 2018 Apr 23;16(1):29. doi: 10.1186/s12969-018-0241-1]. Pediatr Rheumatol Online J. 2017;15(1):84. Published 2017 Dec 21. doi:10.1186/s12969-017-0213-x

Uluduz D, Kürtüncü M, Yapıcı Z, et al. Clinical characteristics of pediatric-onset neuro-Behçet disease. Neurology. 2011;77(21):1900-1905. doi:10.1212/WNL.0b013e318238edeb

Koné-Paut I, Yurdakul S, Bahabri SA, et al. Clinical features of Behçet's disease in children: an international collaborative study of 86 cases. J Pediatr. 1998;132(4):721-725. doi:10.1016/s0022-3476(98)70368-3

Fujikawa S, Suemitsu T. Behçet disease in children: a nationwide retrospective survey in Japan. Acta Paediatr Jpn. 1997;39(2):285-289. doi:10.1111/j.1442-200x.1997.tb03601.x

Koné-Paut I, Darce-Bello M, Shahram F, et al. Registries in rheumatological and musculoskeletal conditions. Paediatric Behçet's disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology (Oxford). 2011;50(1):184-188. doi:10.1093/rheumatology/keq324

O'Duffy JD, Goldstein NP. Neurologic involvement in seven patients with Behçet's disease. Am J Med. 1976;61(2):170-178. doi:10.1016/0002-9343(76)90166-2

Mora P, Menozzi C, Orsoni JG, Rubino P, Ruffini L, Carta A. Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features. Orphanet J Rare Dis. 2013;8:18. Published 2013 Jan 29. doi:10.1186/1750-1172-8-18

Demir S, Acari C, Basaran O, et al. Paediatric Behçet's disease with sinus venous thrombosis: experience from three centres in Turkey. Clin Exp Rheumatol. 2019;37 Suppl 121(6):147-151.

Uygunoğlu U, Siva A. Behçet's Syndrome and Nervous System Involvement. Curr Neurol Neurosci Rep. 2018;18(7):35. Published 2018 May 23. doi:10.1007/s11910-018-0843-5

Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis. 2018;77(6):808-818. doi:10.1136/annrheumdis-2018-213225

D.G. Cogan, Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms, Arch. Ophthalmol. 33 (1945) 144–149.

Kasapçopur O, Ashraf M, Caliskan S, et al. Cogan's syndrome: a rare vasculitis in childhood. J Rheumatol. 2000;27(7):1824-1825.

Gluth MB, Baratz KH, Matteson EL, Driscoll CL. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc. 2006;81(4):483-488. doi:10.4065/81.4.483

Vollertsen RS, McDonald TJ, Younge BR, Banks PM, Stanson AW, Ilstrup DM. Cogan's syndrome: 18 cases and a review of the literature. Mayo Clin Proc. 1986;61(5):344-361. doi:10.1016/s0025-6196(12)61951-x

Iliescu DA, Timaru CM, Batras M, De Simone A, Stefan C. COGAN'S SYNDROME. Rom J Ophthalmol. 2015;59(1):6-13.

Padoan R, Cazzador D, Pendolino AL, et al. Cogan's syndrome: new therapeutic approaches in the biological era. Expert Opin Biol Ther. 2019;19(8):781-788. doi:10.1080/14712598.2019.1611779

Mora P, Calzetti G, Ghirardini S, Rubino P, Gandolfi S, Orsoni J. Cogan's syndrome: State of the art of systemic immunosuppressive treatment in adult and pediatric patients. Autoimmun Rev. 2017;16(4):385-390. doi:10.1016/j.autrev.2017.02.009

Fricker M, Baumann A, Wermelinger F, Villiger PM, Helbling A. A novel therapeutic option in Cogan diseases? TNF-alpha blockers. Rheumatol Int. 2007;27(5):493-495. doi:10.1007/s00296-006-0252-y

Elbers J, Benseler SM. Central nervous system vasculitis in children. Curr Opin Rheumatol. 2008;20(1):47-54. doi:10.1097/BOR.0b013e3282f3177a

Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore). 1988;67(1):20-39. doi:10.1097/00005792-198801000-00002

Benseler SM, Silverman E, Aviv RI, et al. Primary central nervous system vasculitis in children. Arthritis Rheum. 2006;54(4):1291-1297. doi:10.1002/art.21766

Twilt M, Benseler SM. Central nervous system vasculitis in adults and children. Handb Clin Neurol. 2016;133:283-300. doi:10.1016/B978-0-444-63432-0.00016-5

Benseler S, Pohl D. Childhood central nervous system vasculitis. Handb Clin Neurol. 2013;112:1065-1078. doi:10.1016/B978-0-444-52910-7.00024-6

Askalan R, Laughlin S, Mayank S, et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke. 2001;32(6):1257-1262. doi:10.1161/01.str.32.6.1257

Fullerton H, Lynch JK, deVeber G. The call for multicenter studies of pediatric stroke. Stroke. 2006;37(2):330-331. doi:10.1161/01.STR.0000199630.48970.f7

deVeber G, Roach ES, Riela AR, Wiznitzer M. Stroke in children: recognition, treatment, and future directions. Semin Pediatr Neurol. 2000;7(4):309-317. doi:10.1053/spen.2000.20074

Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995;48(11):1343-1348. doi:10.1016/0895-4356(95)00039-9

Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics. 2002;109(1):116-123. doi:10.1542/peds.109.1.116

Benseler SM, deVeber G, Hawkins C, et al. Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease. Arthritis Rheum. 2005;52(7):2159-2167. doi:10.1002/art.21144

Cellucci T, Tyrrell PN, Pullenayegum E, Benseler SM. von Willebrand factor antigen--a possible biomarker of disease activity in childhood central nervous system vasculitis?. Rheumatology (Oxford). 2012;51(10):1838-1845. doi:10.1093/rheumatology/kes156

Twilt M, Benseler SM. The spectrum of CNS vasculitis in children and adults. Nat Rev Rheumatol. 2011;8(2):97-107. Published 2011 Dec 20. doi:10.1038/nrrheum.2011.197

Eleftheriou D, Cox T, Saunders D, Klein NJ, Brogan PA, Ganesan V. Investigation of childhood central nervous system vasculitis: magnetic resonance angiography versus catheter cerebral angiography. Dev Med Child Neurol. 2010;52(9):863-867. doi:10.1111/j.1469-8749.2009.03591.x

Aviv RI, Benseler SM, DeVeber G, et al. Angiography of primary central nervous system angiitis of childhood: conventional angiography versus magnetic resonance angiography at presentation. AJNR Am J Neuroradiol. 2007;28(1):9-15.

Burger IM, Murphy KJ, Jordan LC, Tamargo RJ, Gailloud P. Safety of cerebral digital subtraction angiography in children: complication rate analysis in 241 consecutive diagnostic angiograms. Stroke. 2006;37(10):2535-2539. doi:10.1161/01.STR.0000239697.56147.77

Kirton A, Benseler SM. Central Nervous System Vasculitis. In: Textbook of Pediatric Rheumatology, 8th ed, Petty RE, Laxer RM, Lindsley CB, et al (Eds), Elsevier, 2021. p.500-506.

Hutchinson C, Elbers J, Halliday W, et al. Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study [published correction appears in Lancet Neurol. 2010 Nov;9(11):1045]. Lancet Neurol. 2010;9(11):1078-1084. doi:10.1016/S1474-4422(10)70243-X

Sen ES, Leone V, Abinun M, et al. Treatment of primary angiitis of the central nervous system in childhood with mycophenolate mofetil. Rheumatology (Oxford). 2010;49(4):806-811. doi:10.1093/rheumatology/kep453

Salvarani C, Brown RD Jr, Huston J 3rd, Morris JM, Hunder GG. Treatment of primary CNS vasculitis with rituximab: case report. Neurology. 2014;82(14):1287-1288. doi:10.1212/WNL.0000000000000293